Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study evaluating early discontinuation of steroid treatment in patients with Idiopathic Retroperitoneal Fibrosis, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • steroids

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Idiopathic Retroperitoneal Fibrosis | Phase 4 | Status: RECRUITING